UNC receives more than $40 million from NIH for global clinical trials unit to treat and prevent HIV

UNC has received a seven-year, more than $40 million award from the National Institutes of Health for a clinical trials unit that will implement the scientific agendas of five NIH networks devoted to HIV/AIDS treatment, prevention, and cure research.

UNC receives more than $40 million from NIH for global clinical trials unit to treat and prevent HIV
click to enlarge
Drawing blood samples at the Kanyama Clinic in Lusaka, Zambia. Lusaka is one of five sites in the new Global HIV/AIDS Prevention and Treatment Clinical Trials Unit. Photo: Jorge Alberto Perez

Media Contact: Lisa Chensvold, 919-843-5719, 

Wednesday, February 26, 2014

The University of North Carolina at Chapel Hill has received a seven-year, more than $40 million award from the National Institutes of Health for a clinical trials unit that will implement the scientific agendas of five NIH networks devoted to HIV/AIDS treatment, prevention, and cure research.

The Global HIV Prevention and Treatment Clinical Trials Unit (UNC Global CTU) is led by three co-principal investigators from the UNC School of Medicine: Joseph Eron, MD, professor of medicine; Jeffrey Stringer, MD, professor of obstetrics and gynecology; and Mina Hosseinipour, MD, MPH, professor of medicine. The CTU is housed in the UNC Institute for Global Health & Infectious Diseases.

Read entire story….

Filed under: , ,